Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

被引：0
|
作者：
Yoshikazu Ogawa
Nobunori Takahashi
Atsushi Kaneko
Yuji Hirano
Yasuhide Kanayama
Yuichiro Yabe
Takeshi Oguchi
Takayoshi Fujibayashi
Hideki Takagi
Masahiro Hanabayashi
Koji Funahashi
Masatoshi Hayashi
Seiji Tsuboi
Shuji Asai
Nobuyuki Asai
Takuya Matsumoto
Yasumori Sobue
Naoki Ishiguro
Toshihisa Kojima
机构：
[1] Nakatsugawa Municipal General Hospital,Department of Orthopaedic Surgery
[2] Nagoya University Graduate School of Medicine,Department of Orthopaedic Surgery
[3] Nagoya Medical Center,Department of Orthopedic Surgery and Rheumatology
[4] Toyohashi Municipal Hospital,Department of Rheumatology
[5] Toyota Kosei Hospital,Department of Orthopedic Surgery
[6] Tokyo Shinjuku Medical Center,Department of Rheumatology
[7] Anjo Kosei Hospital,Department of Orthopedic Surgery
[8] Konan Kosei Hospital,Department of Orthopedic Surgery
[9] Nagoya Central Hospital,Department of Orthopedic Surgery
[10] Ichinomiya Municipal Hospital,Department of Orthopedic Surgery
[11] Kariya–Toyota General Hospital,Department of Orthopedic Surgery
[12] Nagano Red Cross Hospital,Department of Rheumatology
[13] Shizuoka Kosei Hospital,Department of Orthopedic Surgery
来源：
Clinical Rheumatology | 2019年 / 38卷
关键词：
Biological therapy; Rheumatoid factor; Tumor necrosis factor; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2757 / 2763
页数：6
相关论文
共 50 条
  • [21] Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis
    Moreland, LW
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1999, 66 (06) : 367 - 374
  • [22] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [23] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [24] Association between bioactive circulating tumor necrosis factor level and tumor necrosis factor-308 polymorphism gene in rheumatoid arthritis
    Marotte, H.
    Arnaud, B.
    Diasparra, J.
    Pachot, A.
    Mougin, B.
    Miossec, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A26 - A26
  • [25] Comparison of Tolerability Between Tumor Necrosis Factor-Inhibitors and Tocilizumab for the Treatment of Rheumatoid Arthritis
    Hishitani, Yoshihiro
    Shima, Yoshihito
    Hirano, Toru
    Hagihara, Keisuke
    Ebina, Kosuke
    Kunugiza, Yasuo
    Shi, Kenrin
    Narazaki, Masashi
    Ogata, Atsushi
    Tomita, Tetsuya
    Tanaka, Toshio
    Kumanogoh, Atsushi
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S219 - S220
  • [26] Rheumatoid arthritis and tumor necrosis factor α
    Abe, T
    Takeuchi, T
    AUTOIMMUNITY, 2001, 34 (04) : 291 - 303
  • [27] Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
    Low, Audrey S. L.
    Lunt, Mark
    Mercer, Louise K.
    Watson, Kath D.
    Dixon, William G.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (06) : 1337 - 1345
  • [28] Prolongation or discontinuation of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis: could this be a realistic scenario?
    Kaltsonoudis, E.
    Pelechas, E.
    Voulgari, P. V.
    Drosos, A. A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 63 - 64
  • [29] Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis
    Harris, Jennifer Toth
    Yang, Yi
    Bentley, John P.
    Chen, Yixin
    Ramachandran, Sujith
    CLINICAL RHEUMATOLOGY, 2024, 43 (08) : 2435 - 2444
  • [30] Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at-308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor
    Marotte, Hubert
    Arnaud, Beatrice
    Diasparra, Jennifer
    Zrioual, Saloua
    Miossec, Pierre
    ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1258 - 1263
12345